1. Home
  2. HQY vs ICL Comparison

HQY vs ICL Comparison

Compare HQY & ICL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HQY
  • ICL
  • Stock Information
  • Founded
  • HQY 2002
  • ICL 1968
  • Country
  • HQY United States
  • ICL Israel
  • Employees
  • HQY N/A
  • ICL N/A
  • Industry
  • HQY Business Services
  • ICL Agricultural Chemicals
  • Sector
  • HQY Consumer Discretionary
  • ICL Industrials
  • Exchange
  • HQY Nasdaq
  • ICL Nasdaq
  • Market Cap
  • HQY 8.7B
  • ICL 8.7B
  • IPO Year
  • HQY 2014
  • ICL N/A
  • Fundamental
  • Price
  • HQY $94.55
  • ICL $7.06
  • Analyst Decision
  • HQY Strong Buy
  • ICL Hold
  • Analyst Count
  • HQY 12
  • ICL 3
  • Target Price
  • HQY $117.42
  • ICL $6.57
  • AVG Volume (30 Days)
  • HQY 1.0M
  • ICL 742.8K
  • Earning Date
  • HQY 09-02-2025
  • ICL 08-06-2025
  • Dividend Yield
  • HQY N/A
  • ICL 2.73%
  • EPS Growth
  • HQY 48.80
  • ICL N/A
  • EPS
  • HQY 1.37
  • ICL 0.30
  • Revenue
  • HQY $1,243,021,000.00
  • ICL $6,873,000,000.00
  • Revenue This Year
  • HQY $9.60
  • ICL $4.71
  • Revenue Next Year
  • HQY $8.97
  • ICL $4.08
  • P/E Ratio
  • HQY $69.06
  • ICL $23.45
  • Revenue Growth
  • HQY 19.21
  • ICL N/A
  • 52 Week Low
  • HQY $65.01
  • ICL $3.79
  • 52 Week High
  • HQY $116.65
  • ICL $7.35
  • Technical
  • Relative Strength Index (RSI)
  • HQY 33.88
  • ICL 56.62
  • Support Level
  • HQY $99.90
  • ICL $7.03
  • Resistance Level
  • HQY $104.93
  • ICL $7.23
  • Average True Range (ATR)
  • HQY 2.72
  • ICL 0.12
  • MACD
  • HQY -1.14
  • ICL 0.02
  • Stochastic Oscillator
  • HQY 1.23
  • ICL 59.15

About HQY HealthEquity Inc.

HealthEquity Inc provides solutions that allow consumers to make healthcare saving and spending decisions. It provides payment processing services, personalized benefit information, the ability to earn wellness incentives, and investment advice to grow their tax-advantaged healthcare savings. It manages consumers' tax-advantaged health savings accounts (HSAs) and other consumer-directed benefits (CDBs) offered by employers, including flexible spending accounts and health reimbursement arrangements (FSAs and HRAs), and administers Consolidated Omnibus Budget Reconciliation Act (COBRA), commuter and other benefits. It also provides investment advisory services to customers whose account balances exceed a certain threshold. HealthEquity generates its revenue in the United States.

About ICL ICL Group Ltd.

ICL Group Ltd is a manufacturer of products based on minerals. The firm is comprised of four segments: phosphate solutions, potash, industrial products, and growing solutions. These segments all contribute to the company's development of agriculture, food, and engineered material products and services. Maximum revenue is generated from its phosphate solutions segment which uses phosphate commodity products, such as phosphate rock and fertilizer-grade phosphoric acid (green phosphoric acid), to produce specialty products. This segment also produces and markets phosphate-based fertilizers. Geographically, the company generates maximum revenue from Brazil followed by, the United States of America, China, United Kingdom, Germany, Spain, Israel, France, India, Netherlands, and other countries.

Share on Social Networks: